GlaxoSmithKline & Tafas Win!!! PTO Loses!!!
 |
Written by Gene Quinn Patent Attorney & IPWatchdog Founder Editor of the IPWatchdog.com Blog Posted: April 1, 2008 @ 2:39 pm Page viewed 1,461 times 
|
 |
GlaxoSmithKline & Tafas Win!!! PTO Loses!!!
In the much anticipated decision from the Eastern District of Virginia the claims and continuation rules enjoined on October 31, 2007, were unceremoniously thrown out! Judge Cacheris concluded:
Because the USPTO’s rulemaking authority under 35 U.S.C. § 2(b)(2) does not extend to substantive rules, and because the Final Rules are substantive in nature, the Court finds that the Final Rules are void as “otherwise not in accordance with law” and “in excess of statutory jurisdiction [and] authority.” 5 U.S.C. § 706(2).
The complete decision is available at:
http://ipwatchdog.com/GSK_v_PTO/gsk_uspto_decision.pdf
Related Posts
- JUST IN: Federal Circuit Denies Vacatur in USPTO Rules Case (♥ ♥ ♥ )
- Federal Circuit to Hear Patent Office Appeal (♥ ♥ ♥ )
- Federal Circuit to Rehear Tafas and GSK v. Doll (♥ ♥ ♥ )
- USPTO v. GSK & Tafas Chronology (♥ ♥ ♥ )
- Oral Arguments Completed in PTO v. GSK, Tafas (♥ ♥ ♥ )
- Call to Action: Amici Briefs in ACLU Gene Patent Challenge (♥ ♥ ♥ )
- Patent Office Assault on Pharma Industry (♥ ♥ )
- Victory to the Patent Office in Claims & Continuations Appeal (♥ ♥ )
- CAFC: Wyeth and Elan Pharma Win A+B Patent Term Adjustment (♥ ♥ )
- Reexamination of Patents Listed in the FDA's Orange Book: Surprising Facts For Brands and Generics (♥ ♥ )
Share & Enjoy With Social Networks
Tags & Categories
Posted in: IP News, IPWatchdog.com Blog, Patent Fools™, Pharma
 |
